April 21, 2023
The University of Cincinnati's Alberto Espay will present Parkinson's disease research at the American Academy of Neurology's annual meeting April 22-27 in Boston.
October 4, 2022
University of Cincinnati researchers led by Alberto Espay and Andrea Sturchio published new research that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
December 7, 2023
The UC Gardner Neuroscience Institute has received $19 million in federal funding from the National Institutes of Health to serve as the lead center for a Phase 2 clinical trial that will study the efficacy of a new monoclonal antibody treatment for patients ineligible for currently available treatments.
October 30, 2023
The University of Cincinnati Gardner Neuroscience Institute has been renewed as the National Coordinating Center of the National Institutes of Health StrokeNet, overseeing all NIH-funded adult and pediatric stroke trials nationwide.
February 7, 2024
University of Cincinnati neurology experts are presenting research at the International Stroke Conference 2024, Feb. 7-9 in Phoenix, Arizona.
March 18, 2024
An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
May 15, 2024
The University of Cincinnati’s Yasmin Aziz will present research at the European Stroke Organisation Conference that found severe ischemic strokes with the most severe damage are rare in the total stroke patient population.
August 4, 2021
UC researchers launched a new study looking treating a common brain problem that results after therapy for cancer.
August 27, 2021
UC research examining a music app to help breast cancer survivors is mentioned by Forbes.
May 18, 2021
UC's Daniel Pomeranz Krummel, PhD, discusses new brain cancer research with Liz Bonis on Local 12's What's Happening in Health program.